Increasing clinical severity during a dengue virus type 3 Cuban epidemic: Deep sequencing of evolving viral populations

Journal of Virology

Volumn 90, Issue 9, 2016, Pages 4320-4333

  Rodriguez Roche, Rosmari ^a   Blanc, Hervé ^b   Bordería, Antonio V ^b   Díaz, Gisell ^a   Henningsson, Rasmus ^b,c   Gonzalez, Daniel ^a   Santana, Emidalys ^a   Alvarez, Mayling ^a   Castro, Osvaldo ^a   Fontes, Magnus ^b   Vignuzzi, Marco ^b   Guzman, Maria G ^a  

^a INSTITUTO DE MEDICINA TROPICAL PEDRO KOURÍ   (Cuba)

^b INSTITUT PASTEUR   (France)

^c LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; IMMUNOGLOBULIN G; VIRUS ANTIBODY; VIRUS RNA;

ALLELE; ARTICLE; BLOOD SAMPLING; CONSENSUS SEQUENCE; CONTROLLED STUDY; CUBAN; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 3; DISEASE COURSE; DISEASE SEVERITY; EPIDEMIC; GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; GENETIC VARIATION; GENOTYPE; HUMAN; NONHUMAN; NS2B GENE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIMARY INFECTION; PRIORITY JOURNAL; SECONDARY INFECTION; SEQUENCE ANALYSIS; VIRUS ENVELOPE; VIRUS MUTATION; VIRUS STRAIN; AMINO ACID SUBSTITUTION; CLASSIFICATION; CUBA; DENGUE VIRUS; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; IMMUNOLOGY; MALE; MOLECULAR EVOLUTION; SEVERITY OF ILLNESS INDEX; VIROLOGY; VIRUS GENOME;

AMINO ACID SUBSTITUTION; ANTIBODIES, VIRAL; CONSENSUS SEQUENCE; CUBA; DENGUE; DENGUE VIRUS; EVOLUTION, MOLECULAR; FEMALE; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IMMUNOGLOBULIN G; MALE; PHYLOGENY; RNA, VIRAL; SEVERITY OF ILLNESS INDEX;

EID: 84964953214     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02647-15     Document Type: Article

References (60)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. 2013. The global distribution and burden of dengue. Nature 496:504-507. http://dx.doi.org/10.1038/nature12060.
2. WHO/TDR. 2009. Dengue guidelines for diagnosis, treatment, prevention and control-new edition. World Health Organization Press, Geneva, Switzerland.
3. San Martin JL, Brathwaite O, Zambrano B, Solorzano JO, Bouckenooghe A, Dayan GH, Guzman MG. 2010. The epidemiology of dengue in the Americas over the last three decades: a worrisome reality.AmJ Trop Med Hyg 82:128-135. http://dx.doi.org/10.4269/ajtmh.2010.09-0346.
4. Rice CM, Lenches EM, Eddy SR, Shin SJ, Sheets RL, Strauss JH. 1985. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726-733. http://dx.doi.org/10.1126/science.4023707.
5. WHO. 1997. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control, 2nd ed. World Health Organization Press, Geneva, Switzerland.
6. Rodriguez-Roche R, Gould EA. 2013. Understanding the dengue viruses and progress towards their control. Biomed Res Int 2013:690835. http://dx.doi.org/10.1155/2013/690835.
7. Guzman MG, Harris E. 2015. Dengue. Lancet 385:453-465. http://dx.doi.org/10.1016/S0140-6736(14)60572-9.
8. Kouri GP, Guzman MG, Bravo JR. 1987. Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans R Soc Trop Med Hyg 81:821-823. http://dx.doi.org/10.1016/0035-9203(87)90042-3.
9. Guzman MG, Kouri G. 2008. Dengue haemorrhagic fever integral hypothesis: confirming observations, 1987-2007. Trans R Soc Trop Med Hyg 102:522-523. http://dx.doi.org/10.1016/j.trstmh.2008.03.001.
10. Rodriguez-Roche R, Sanchez L, Burgher Y, Rosario D, Alvarez M, Kouri G, Halstead SB, Gould EA, Guzman MG. 2011. Virus role during intraepidemic increase in dengue disease severity. Vector Borne Zoonotic Dis 11:675-681. http://dx.doi.org/10.1089/vbz.2010.0177.
11. Guzman MG, Kouri G, Halstead SB. 2000. Do escape mutants explain rapid increases in dengue case-fatality rates within epidemics? Lancet 355: 1902-1903. http://dx.doi.org/10.1016/S0140-6736(00)02303-5.
12. Pelaez O, Guzman MG, Kouri G, Perez R, San Martin JL, Vazquez S, Rosario D, Mora R, Quintana I, Bisset J, Cancio R, Masa AM, Castro O, Gonzalez D, Avila LC, Rodriguez R, Alvarez M, Pelegrino JL, Bernardo L, Prado I. 2004. Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis 10:719-722. http://dx.doi.org/10.3201/eid1004.030271.
13. Rodriguez-Roche R, Hinojosa Y, Guzman MG. 2014. First dengue haemorrhagic fever epidemic in the Americas, 1981: insights into the causative agent. Arch Virol 159:3239-3247. http://dx.doi.org/10.1007/s00705-014-2188-y.
14. Rodriguez-Roche R, Alvarez M, Gritsun T, Halstead S, Kouri G, Gould EA, Guzman MG. 2005. Virus evolution during a severe dengue epidemic in Cuba, 1997. Virology 334:154-159. http://dx.doi.org/10.1016/j.virol.2005.01.037.
15. Lin SR, Hsieh SC, Yueh YY, Lin TH, Chao DY, Chen WJ, King CC, Wang WK. 2004. Study of sequence variation of dengue type 3 virus in naturally infected mosquitoes and human hosts: implications for transmission and evolution. J Virol 78:12717-12721. http://dx.doi.org/10.1128/JVI.78.22.12717-12721.2004.
16. Descloux E, Cao-Lormeau VM, Roche C, De Lamballerie X. 2009. Dengue 1 diversity and microevolution, French Polynesia 2001-2006: connection with epidemiology and clinics. PLoS Negl Trop Dis 3:e493. http://dx.doi.org/10.1371/journal.pntd.0000493.
17. Thai KT, Henn MR, Zody MC, Tricou V, Nguyet NM, Charlebois P, Lennon NJ, Green L, de Vries PJ, Hien TT, Farrar J, van Doorn HR, de Jong MD, Birren BW, Holmes EC, Simmons CP. 2012. High-resolution analysis of intrahost genetic diversity in dengue virus serotype 1 infection identifies mixed infections. J Virol 86:835-843. http://dx.doi.org/10.1128/JVI.05985-11.
18. Parameswaran P, Charlebois P, Tellez Y, Nunez A, Ryan EM, Malboeuf CM, Levin JZ, Lennon NJ, Balmaseda A, Harris E, Henn MR. 2012. Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J Virol 86: 8546-8558. http://dx.doi.org/10.1128/JVI.00736-12.
19. Romano CM, Lauck M, Salvador FS, Lima CR, Villas-Boas LS, Araujo ES, Levi JE, Pannuti CS, O'Connor D, Kallas EG. 2013. Inter-and intra-host viral diversity in a large seasonal DENV2 outbreak. PLoS One 8:e70318. http://dx.doi.org/10.1371/journal.pone.0070318.
20. Sim S, Aw PP, Wilm A, Teoh G, Hue KD, Nguyen NM, Nagarajan N, Simmons CP, Hibberd ML. 2015. Tracking dengue virus intra-host ge-netic diversity during human-to-mosquito transmission. PLoS Negl Trop Dis 9:e0004052. http://dx.doi.org/10.1371/journal.pntd.0004052.
21. Sessions OM, Wilm A, Kamaraj US, Choy MM, Chow A, Chong Y, Ong XM, Nagarajan N, Cook AR, Ooi EE. 2015. Analysis of dengue virus genetic diversity during human and mosquito infection reveals genetic constraints. PLoS Negl Trop Dis 9:e0004044. http://dx.doi.org/10.1371/journal.pntd.0004044.
22. Villordo SM, Filomatori CV, Sanchez-Vargas I, Blair CD, Gamarnik AV. 2015. Dengue virus RNA structure specialization facilitates host adaptation. PLoS Pathog 11:e1004604. http://dx.doi.org/10.1371/journal.ppat.1004604.
23. Henchal EA, McCown JM, Seguin MC, Gentry MK, Brandt WE. 1983. Rapid identification of dengue virus isolates by using monoclonal antibodies in an indirect immunofluorescence assay. Am J Trop Med Hyg 32:164-169.
24. Pan American Health Organization. 1994. Dengue and dengue hemorrhagic fever in the Americas: guidelines for prevention and control. Scientific publication no. 548. Pan American Health Organization, Washington, DC.
25. Vazquez S, Bravo JR, Perez AB, Guzman MG. 1997. Inhibition ELISA. Its utility for classifying a case of dengue. Rev Cubana Med Trop 49:108-112 (In Spanish.).
26. Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N. 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 22: 250-254.
27. Alvarez M, Rodriguez-Roche R, Bernardo L, Morier L, Guzman G. 2005. Improved dengue virus plaque formation on BHK21 and LLCMK2 cells: evaluation of some factors. Dengue Bull 29:49-57.
28. Guzman MG, Kouri G, Bravo J, Soler M, Martinez E. 1991. Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic. Mem Inst Oswaldo Cruz 86:367. http://dx.doi.org/10.1590/S0074-02761991000300011.
29. Christenbury JG, Aw PP, Ong SH, Schreiber MJ, Chow A, Gubler DJ, Vasudevan SG, Ooi EE, Hibberd ML. 2010. A method for full genome sequencing of all four serotypes of the dengue virus. J Virol Methods 169:202-206. http://dx.doi.org/10.1016/j.jviromet.2010.06.013.
30. Isakov O, Borderia AV, Golan D, Hamenahem A, Celniker G, Yoffe L, Blanc H, Vignuzzi M, Shomron N. 2015. Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum. Bioinformatics 31:2141-2150. http://dx.doi.org/10.1093/bioinformatics/btv101.
31. Borderia AV, Isakov O, Moratorio G, Henningsson R, Aguera-Gonzalez S, Organtini L, Gnadig NF, Blanc H, Alcover A, Hafenstein S, Fontes M, Shomron N, Vignuzzi M. 2015. Group selection and contribution of minority variants during virus adaptation determines virus fitness and phenotype. PLoS Pathog 11:e1004838. http://dx.doi.org/10.1371/journal.ppat.1004838.
32. Li K, Venter E, Yooseph S, Stockwell TB, Eckerle LD, Denison MR, Spiro DJ, Methe BA. 2010. ANDES: statistical tools for the analyses of deep sequencing. BMC Res Notes 3:199. http://dx.doi.org/10.1186/1756-0500-3-199.
33. Kruskal JB. 1964. Multidimensional scaling by optimizing goodness of fit to a nonmetric hypothesis. Psychometrika 29:1-27. http://dx.doi.org/10.1007/BF02289565.
34. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. 1997. The Clustal_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25: 4876-4882. http://dx.doi.org/10.1093/nar/25.24.4876.
35. Huelsenbeck JP, Ronquist F. 2001. MRBAYES: Bayesian inference of phylogenetic trees. Bioinformatics 17:754-755. http://dx.doi.org/10.1093/bioinformatics/17.8.754.
36. Drummond AJ, Rambaut A. 2007. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7:214. http://dx.doi.org/10.1186/1471-2148-7-214.
37. Betts MJ, Russell RB. 2003. Amino acid properties and consequences of substitutions, p 289-316. In Barnes MR, Gray IC (ed), Bioinformatics for geneticists. Wiley, Hoboken, NJ.
38. Ecker M, Allison SL, Meixner T, Heinz FX. 1999. Sequence analysis and genetic classification of tick-borne encephalitis viruses from Europe and Asia. J Gen Virol 80:179-185. http://dx.doi.org/10.1099/0022-1317-80-1-179.
39. Klein DE, Choi JL, Harrison SC. 2013. Structure of a dengue envelope protein late-stage fusion intermediate. J Virol 87:2287-2293. http://dx.doi.org/10.1128/JVI.02957-12.
40. Tsai WY, Hsieh SC, Lai CY, Lin HE, Nerurkar VR, Wang WK. 2012. C-terminal helical domains of dengue virus type 4 E protein affect the expression/stability of prM protein and conformation of prM and E proteins. PLoS One 7:e52600. http://dx.doi.org/10.1371/journal.pone.0052600.
41. Yap TL, Xu T, Chen YL, Malet H, Egloff MP, Canard B, Vasudevan SG, Lescar J. 2007. Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol 81: 4753-4765. http://dx.doi.org/10.1128/JVI.02283-06.
42. Coffey LL, Vasilakis N, Brault AC, Powers AM, Tripet F, Weaver SC. 2008. Arbovirus evolution in vivo is constrained by host alternation. Proc Natl Acad Sci U S A 105:6970-6975. http://dx.doi.org/10.1073/pnas.0712130105.
43. Andino R, Domingo E. 2015. Viral quasispecies. Virology 479-480:46-51. http://dx.doi.org/10.1016/j.virol.2015.03.022.
44. Acevedo A, Brodsky L, Andino R. 2014. Mutational and fitness landscapes of an RNA virus revealed through population sequencing. Nature 505:686-690. http://dx.doi.org/10.1038/nature12861.
45. OhAinle M, Balmaseda A, Macalalad AR, Tellez Y, Zody MC, Saborio S, Nunez A, Lennon NJ, Birren BW, Gordon A, Henn MR, Harris E. 2011. Dynamics of dengue disease severity determined by the interplay between viral genetics and serotype-specific immunity. Sci Transl Med 3:114ra128. http://dx.doi.org/10.1126/scitranslmed.3003084.
46. Rodriguez-Roche R, Alvarez M, Holmes EC, Bernardo L, Kouri G, Gould EA, Halstead S, Guzman MG. 2005. Dengue virus type 3, Cuba, 2000-2002. Emerg Infect Dis 11:773-774. http://dx.doi.org/10.3201/eid1105.040916.
47. Rodriguez-Roche R, Lopez Matilla L, Alvarez Vera M, Morier Diaz L, Guzman Tirado MG. 2012. Biological properties of virus dengue-3 strains isolated during the epidemic occurred in Havana, 2001-2002. Rev Cubana Med Trop 64:187-198. (In Spanish.).
48. Hsieh YH, de Arazoza H, Lounes R. 2013. Temporal trends and regional variability of 2001-2002 multiwave DENV-3 epidemic in Havana City: did Hurricane Michelle contribute to its severity? Trop Med Int Health 18: 830-838. http://dx.doi.org/10.1111/tmi.12105.
49. Falgout B, Pethel M, Zhang YM, Lai CJ. 1991. Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 65:2467-2475.
50. Noble CG, Seh CC, Chao AT, Shi PY. 2012. Ligand-bound structures of the dengue virus protease reveal the active conformation. J Virol 86:438-446. http://dx.doi.org/10.1128/JVI.06225-11.
51. Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim SP, Yin Z, Keller TH, Vasudevan SG, Hommel U. 2006. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 13:372-373. http://dx.doi.org/10.1038/nsmb1073.
52. Novella IS, Zarate S, Metzgar D, Ebendick-Corpus BE. 2004. Positive selection of synonymous mutations in vesicular stomatitis virus. J Mol Biol 342:1415-1421. http://dx.doi.org/10.1016/j.jmb.2004.08.003.
53. de Fabritus L, Nougairede A, Aubry F, Gould EA, de Lamballerie X. 2015. Attenuation of tick-borne encephalitis virus using large-scale random codon re-encoding. PLoS Pathog 11:e1004738. http://dx.doi.org/10.1371/journal.ppat.1004738.
54. Nougairede A, De Fabritus L, Aubry F, Gould EA, Holmes EC, de Lamballerie X. 2013. Random codon re-encoding induces stable reduction of replicative fitness of Chikungunya virus in primate and mosquito cells. PLoS Pathog 9:e1003172. http://dx.doi.org/10.1371/journal.ppat.1003172.
55. Domingo E, Sheldon J, Perales C. 2012. Viral quasispecies evolution. Microbiol Mol Biol Rev 76:159-216. http://dx.doi.org/10.1128/MMBR.05023-11.
56. Alvarez M, Rodriguez-Roche R, Bernardo L, Vazquez S, Morier L, Gonzalez D, Castro O, Kouri G, Halstead SB, Guzman MG. 2006. Dengue hemorrhagic Fever caused by sequential dengue 1-3 virus infections over a long time interval: Havana epidemic, 2001-2002. Am J Trop Med Hyg 75:1113-1117.
57. Guzman MG, Alvarez A, Vazquez S, Alvarez M, Rosario D, Pelaez O, Cruz G, Rodriguez R, Pavon A, Gonzalez A, Morier L, Ruiz D, Kouri G, Halstead SB. 2012. Epidemiological studies on dengue virus type 3 in Playa municipality, Havana, Cuba, 2001-2002. Int J Infect Dis 16:e198-e203. http://dx.doi.org/10.1016/j.ijid.2011.09.026.
58. Messer WB, Gubler DJ, Harris E, Sivananthan K, de Silva AM. 2003. Emergence and global spread of a dengue serotype 3, subtype III virus. Emerg Infect Dis 9:800-809. http://dx.doi.org/10.3201/eid0907.030038.
59. Katzelnick LC, Fonville JM, Gromowski GD, Bustos Arriaga J, Green A, James SL, Lau L, Montoya M, Wang C, VanBlargan LA, Russell CA, Thu HM, Pierson TC, Buchy P, Aaskov JG, Munoz-Jordan JL, Vasilakis N, Gibbons RV, Tesh RB, Osterhaus AD, Fouchier RA, Durbin A, Simmons CP, Holmes EC, Harris E, Whitehead SS, Smith DJ. 2015. Dengue viruses cluster antigenically but not as discrete serotypes. Science 349:1338-1343. http://dx.doi.org/10.1126/science.aac5017.
60. Holmes EC. 2003. Patterns of intra-and interhost nonsynonymous variation reveal strong purifying selection in dengue virus. J Virol 77:11296-11298 http://dx.doi.org/10.1128/JVI.77.20.11296-11298.2003.